In his interview, Professor Taskén, who is also a Group Leader at NCMM, talks about the importance of finding ways to personalise cancer treatments. He also discusses the ways in which he and his colleagues at NCMM are trying to challenge the traditional methods and thinking when it comes to developing and testing cancer treatments.
You can read the full article on Titan.uio.no .
Professor Taskén will be speaking at Day Two of the Oslo Life Science Conference 2017 on the 16 February.
Find out more about the conference here.